Features
- All day comfort*
- Successful and easy fitting1
- Widest range versus competitor 1-day multifocals2
- Amazingly affordable3,4
- Sustainably made and net plastic neutral†‡3
Discover a new era of clariti® 1 day multifocal.
New design. New edge. New parameters.
We created the next generation of clariti® 1 day so patients with presbyopia can see like they used to5. clariti® 1 day multifocal 3 Add features a new design, new edge and new parameters so you can help patients be who they are without compromise and live life to the fullest6 from the very first fit1.
CooperVision Binocular Progressive System®
An innovative 3 Add multifocal system that uses different lens designs to optimize vision for all levels of presbyopia, even as prescriptions and vision needs change5.
Successful and Easy Fitting
The simple and highly effective fitting process enables you to deliver the right contact lenses efficiently and successfully to your patients with presbyopia1.
- At least 98% fit success with no more than 2 pairs of lenses1,7,8.
- At least 83% fit success with the first pair of lenses1,8.
More confident fitting is a download away§
With CooperVision’s OptiExpert® fitting app, you can save valuable chair time with a fast, accurate fit§9.
All Day Comfort
Optimized Comfort Edge™
clariti® 1 day multifocal 3 Add now has Optimized Comfort Edge™ to help provide a high level of comfort from the first fit10.
WetLoc® Technology
Locks in water molecules to support excellent all-day comfort and naturally healthy eyes|.
Amazingly Affordable
True to the clariti® 1 day family, this latest contact lens features important innovations at an excellent value – making it a great choice for your patients with presbyopia3,10,11.
- 4 out of 5 Eye Care Professionals agree clariti® 1 day offers new wearers excellent value for the money11.
New Parameters
CooperVision 1 day silicone hydrogel multifocals have the widest range versus competitor 1-day multifocals enabling you to fit more patients with presbyopia2.
Lens Technology
Product Details
-10.50D to -12.00D (0.50D steps)
Med: +1.50D to +1.75D
High: +2.00D to +2.50D
* Manufacturer's quoted core water content.
† clariti® 1 day orders includes clariti® 1 day sphere, clariti® 1 day toric, and clariti® 1 day multifocal products sold and distributed by CooperVision in the US.
‡ Net plastic neutrality is established by purchasing credits from Plastic Bank®. A credit represents the collection and conversion of one kilogram of plastic that may reach or be destined for waterways. CooperVision purchases credits equal to the weight of plastic in clariti® 1 day orders in a specified time period. clariti® 1 day plastic is determined by the weight of plastic in the blister, the lens, and the secondary package, including laminates, adhesives, and auxiliary inputs (e.g. ink).
§ Based on retrospective analysis of 26 patients (52 eyes) with subjective refractions ranging between +5.00D to -6.00D and ≤ -1.00 D cylinder.
| Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
References:
CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; n=90 habitual MFCL wearers.
CVI data on file 2024. Based on prescription option combinations (sph and add) available across all daily disposable multifocal soft lenses from CVI, JJV, B+L and Alcon in USA Feb 2024.
CVI data on file, 2022.
CVI data on file 2022. Verve Online Survey with US ECPs who fit clariti® 1 day or private label version. n=121 (79% strongly agree/agree).
CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add; with ratings from 85 to 89 out of 100; n=90 habitual MFCL wearers.
CVI data on file 2020. YouGov Plc online consumer survey Nov/Dec 2019 in Germany, UK, Spain, Japan, USA. N=5,347 Contact Lens wearers ("consumers"), screened from total N=35,397 adults. Data weighted and representative of adults in each market (aged 18+).
CVI data on file 2020. Prospective, double-masked, bilateral, one-week dispensing study UK with MyDay® multifocal; n=104 habitual multifocal contact lens wearers.
CVI data on file 2021. Prospective, subject-masked, randomized, bilateral, two-week dispensing study at 5 US sites with MyDay® multifocal; n=58 habitual multifocal contact lens wearers.
CVI data on file 2019. Retrospective analysis; N=55 subjects (110 eyes); DV Rx +1.25D to -3.25D, add powers +1.25 to +2.50DS.
CVI data on file 2021. Prospective, double-masked, bilateral, one-week dispensing study with clariti® 1 day multifocal 3 add with a rating of 88 out of 100; n=90 habitual MFCL wearers.
CVI data on file 2022. Verve Online Survey with US ECPs who fit clariti® 1 day or private label version. n=121 (79% strongly agree/agree).